The University of Chicago Header Logo

Connection

Peter Pytel to Animals

This is a "connection" page, showing publications Peter Pytel has written about Animals.
Connection Strength

0.279
  1. Pathogenesis of septic encephalopathy. Curr Opin Neurol. 2009 Jun; 22(3):283-7.
    View in: PubMed
    Score: 0.022
  2. Muscle diseases: the muscular dystrophies. Annu Rev Pathol. 2007; 2:87-109.
    View in: PubMed
    Score: 0.019
  3. HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis. J Clin Invest. 2020 07 01; 130(7):3848-3864.
    View in: PubMed
    Score: 0.012
  4. Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease. Stroke. 2019 03; 50(3):738-744.
    View in: PubMed
    Score: 0.011
  5. TDP-43 proteinopathy in Theiler's murine encephalomyelitis virus infection. PLoS Pathog. 2019 02; 15(2):e1007574.
    View in: PubMed
    Score: 0.011
  6. Evidence for an early innate immune response in the motor cortex of ALS. J Neuroinflammation. 2017 06 26; 14(1):129.
    View in: PubMed
    Score: 0.010
  7. RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke. 2017 01; 48(1):187-194.
    View in: PubMed
    Score: 0.009
  8. CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells. Cancer Res. 2016 10 01; 76(19):5671-5682.
    View in: PubMed
    Score: 0.009
  9. Eps 15 Homology Domain (EHD)-1 Remodels Transverse Tubules in Skeletal Muscle. PLoS One. 2015; 10(9):e0136679.
    View in: PubMed
    Score: 0.009
  10. Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy. Hum Mol Genet. 2015 Oct 15; 24(20):5711-9.
    View in: PubMed
    Score: 0.009
  11. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence. Expert Rev Neurother. 2015; 15(7):741-52.
    View in: PubMed
    Score: 0.008
  12. Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma. J Immunol. 2015 Jul 01; 195(1):367-76.
    View in: PubMed
    Score: 0.008
  13. ßIII-Tubulin Regulates Breast Cancer Metastases to the Brain. Mol Cancer Ther. 2015 May; 14(5):1152-61.
    View in: PubMed
    Score: 0.008
  14. Loss of Nfkb1 leads to early onset aging. Aging (Albany NY). 2014 Nov; 6(11):931-43.
    View in: PubMed
    Score: 0.008
  15. Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome. Exp Neurol. 2015 Aug; 270:88-94.
    View in: PubMed
    Score: 0.008
  16. EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development. Dev Biol. 2014 Mar 15; 387(2):179-90.
    View in: PubMed
    Score: 0.008
  17. Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity. Am J Pathol. 2014 Jan; 184(1):248-59.
    View in: PubMed
    Score: 0.008
  18. Selective inhibition of caspases in skeletal muscle reverses the apoptotic synaptic degeneration in slow-channel myasthenic syndrome. Hum Mol Genet. 2014 Jan 01; 23(1):69-77.
    View in: PubMed
    Score: 0.007
  19. Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine. 2014 Jan; 10(1):149-57.
    View in: PubMed
    Score: 0.007
  20. Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas. Cancer Med. 2013 Aug; 2(4):457-67.
    View in: PubMed
    Score: 0.007
  21. Animal models of antimuscle-specific kinase myasthenia. Ann N Y Acad Sci. 2012 Dec; 1274:140-7.
    View in: PubMed
    Score: 0.007
  22. Selective knockdown of mutant SOD1 in Schwann cells ameliorates disease in G85R mutant SOD1 transgenic mice. Neurobiol Dis. 2012 Oct; 48(1):52-7.
    View in: PubMed
    Score: 0.007
  23. Endocytic recycling proteins EHD1 and EHD2 interact with fer-1-like-5 (Fer1L5) and mediate myoblast fusion. J Biol Chem. 2011 Mar 04; 286(9):7379-88.
    View in: PubMed
    Score: 0.006
  24. Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy. Hum Mol Genet. 2011 Feb 15; 20(4):779-89.
    View in: PubMed
    Score: 0.006
  25. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Cancer Res. 2010 Jul 15; 70(14):5840-50.
    View in: PubMed
    Score: 0.006
  26. Myoferlin regulation by NFAT in muscle injury, regeneration and repair. J Cell Sci. 2010 Jul 15; 123(Pt 14):2413-22.
    View in: PubMed
    Score: 0.006
  27. Myoferlin is required for insulin-like growth factor response and muscle growth. FASEB J. 2010 Apr; 24(4):1284-95.
    View in: PubMed
    Score: 0.006
  28. Nesprin-1 mutations in human and murine cardiomyopathy. J Mol Cell Cardiol. 2010 Apr; 48(4):600-8.
    View in: PubMed
    Score: 0.006
  29. Impaired exercise tolerance and skeletal muscle myopathy in sulfonylurea receptor-2 mutant mice. Am J Physiol Regul Integr Comp Physiol. 2009 Oct; 297(4):R1144-53.
    View in: PubMed
    Score: 0.006
  30. Disruption of nesprin-1 produces an Emery Dreifuss muscular dystrophy-like phenotype in mice. Hum Mol Genet. 2009 Feb 15; 18(4):607-20.
    View in: PubMed
    Score: 0.005
  31. The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion. J Biol Chem. 2008 Jul 18; 283(29):20252-60.
    View in: PubMed
    Score: 0.005
  32. Capture of magnetic carriers within large arteries using external magnetic fields. J Drug Target. 2008 May; 16(4):262-8.
    View in: PubMed
    Score: 0.005
  33. Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy. Clin Cancer Res. 2007 Oct 15; 13(20):6217-23.
    View in: PubMed
    Score: 0.005
  34. Interferon-gamma induced medulloblastoma in the developing cerebellum. J Neurosci. 2004 Nov 10; 24(45):10074-83.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.